MEDIA CALL: FDA’s Proposed Order on Phenylephrine - 11/7/2024

A media availability to discuss the FDA's proposal to end the use of oral phenylephrine as an active ingredient in over-the-counter (OTC) monograph drug products.
On the call:
• Peter Stein, M.D., director of the Office of New Drugs within the FDA’s Center for Drug Evaluation and Research
• Theresa Michele, M.D., director of the Office of Nonprescription Drugs within the FDA’s Center for Drug Evaluation and Research